EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rat Pharmacokinetics and In Vitro Metabolite Identification of KM-819, a Parkinson’s Disease Candidate, Using LC-MS/MS and LC-HRMS

Hae-In Choi, Taeheon Kim, Jin Woo Kim iD, Gi Ju Lee, Jinyoung Choi, Yoon-Jee Chae iD, Eunhee Kim, Tae-Sung Koo iD

Molecules · 2024

DOI: 10.3390/molecules29051004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Hae-In Choi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Parkinson Disease, Formates, Organic Chemicals. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

FAF1 (FAS-associated factor 1) is involved in the activation of Fas cell surface death receptors and plays a role in apoptosis and necrosis. In patients with Parkinson’s disease, FAF1 is overexpressed in dopaminergic neurons in the substantia nigra. KM-819, an FAF1 inhibitor, has shown potential for preventing dopaminergic neuronal cell death, promoting the degradation of α-synuclein and preventing its accumulation. This study aimed to develop and validate a quantitative analytical method for determining KM-819 levels in rat plasma using liquid chromatography–tandem mass spectrometry. This method was then applied to pharmacokinetic (PK) studies in rats. The metabolic stability of KM-819 was assessed in rat, dog, and human hepatocytes. In vitro metabolite identification and metabolic pathways were investigated in rat, dog, and human hepatocytes. The structural analog of KM-819, namely N-[1-(4-bromobenzyl)-3,5-dimethyl-1H-pyrazol-4-yl]-2-(phenylsulfanyl) acetamide, served as the internal standard (IS). Proteins were precipitated from plasma samples using acetonitrile. Analysis was carried out using a reverse-phase C18 column with a mobile phase consisting of 0.1% formic acid in distilled water and 0.1% formic acid in acetonitrile. The analytical method developed for KM-819 exhibited linearity within the concentration range of 0.002–10 μg/mL in rat plasma. The precision and accuracy of the intra- and inter-day measurements were

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryParkinson DiseaseFormatesOrganic ChemicalsRatsHumansAnimalsDogsChromatography, LiquidLiquid Chromatography-Mass SpectrometryAcetonitrilesReproducibility of ResultsChromatography, High Pressure LiquidAdaptor Proteins, Signal TransducingApoptosis Regulatory Proteins

Stichwörter der Autor:innen

FAF1 inhibitorKM-819LC-HRMSLC-MS/MSmetabolite identificationpharmacokinetics

Substanzen

formic acidKM-819AcetonitrilesFAF1 protein, humanAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsFormatesOrganic Chemicals

Autor:innen und Institutionen

  • Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea.
  • College of Pharmacy, Woosuk University, Wanju 55338, Republic of Korea.
  • College of Biological Sciences and Biotechnology, Chungnam National University, Daejeon 34134, Republic of Korea.
  • Biopharmaceutical Division, Kainos Medicine Inc., Seongnam 13488, Republic of Korea.

ORCID-Profile: Jin Woo Kim, Yoon-Jee Chae, Tae-Sung Koo

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Choi, H. I., Kim, T., Kim, J. W., Lee, G. J., Choi, J., Chae, Y. J., Kim, E., & Koo, T. S. (2024). Rat Pharmacokinetics and In Vitro Metabolite Identification of KM-819, a Parkinson’s Disease Candidate, Using LC-MS/MS and LC-HRMS. Molecules. https://doi.org/10.3390/molecules29051004

Vancouver

Choi HI, Kim T, Kim JW, Lee GJ, Choi J, Chae YJ, et al. Rat Pharmacokinetics and In Vitro Metabolite Identification of KM-819, a Parkinson’s Disease Candidate, Using LC-MS/MS and LC-HRMS. Molecules. 2024. doi:10.3390/molecules29051004

BibTeX
@article{Choi2024,
  author = {Choi, Hae-In and Kim, Taeheon and Kim, Jin Woo and Lee, Gi Ju and Choi, Jinyoung and Chae, Yoon-Jee and Kim, Eunhee and Koo, Tae-Sung},
  title = {Rat Pharmacokinetics and In Vitro Metabolite Identification of KM-819, a Parkinson’s Disease Candidate, Using LC-MS/MS and LC-HRMS},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29051004}
}
Kostenlos starten →